AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
NEWS & MEDIA
Partex and Singapore’s Experimental Drug Development Centre collaborate to bring
Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Partex NV announces collaboration with Althea DRF Lifesciences to provide
Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF…
Innovative AI technology in oncology: Partex Group presents results from
During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the…
Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment
Frankfurt, Germany; 14 March 2024 Partex Group, a pioneer in AI-driven drug discovery, today announces a collaboration with global pharmaceutical…
Innoplexus and AIO Studien gGmbH are jointly announcing the start
January 02, 2024 – Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health…
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…
AI supports targeted therapy recommendations fortumor diseases – BMBF funds
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
OncoCoin AG donates for a charity bicycle tour: Tour of
Bad Hersfeld / Germany, Aug 02, 2022– Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took…
Innoplexus and Innovatrix capital partner to bring about new risk-transfer
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…
Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform
COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston,…
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for
COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN, Germany,…
Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen
Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz…
Der Pharma-Visionär
Mit künstlicher Intelligenz gegen Krankheiten: Wie Gunjan Bhardwaj die Regeln der Arzneimittelforschung umschreiben will – für schnellere Ergebnisse und bessere…
Künstliche Intelligenz unterstützt Suche nach Wirkstoff gegen Corona
Hessen fördert Forschungsprojekt mit rund 1,4 Mio. Euro. Mit einem Zuschuss von 1,4 Mio. Euro unterstützt Hessen die Entwicklung eines Wirkstoffkandidaten…
New app for cancer patients
Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…
Role of AI soars in tackling Covid-19 pandemic
For the first time in a pandemic, Artificial Intelligence (AI) is playing a role like never before in areas ranging…
Innoplexus Announces Major Findings in Potential Combination Therapies for COVID-19
Disclaimer: This press release and our findings are solely intended as information for the scientific community. This content is not intended…
Innoplexus wins Silver Edison Award for OntosightⓇ Explore
Frankfurt, Germany, March 26, 2020 — Innoplexus AG has been honored with the Silver Edison Award 2020 for its proprietary…
Innoplexus: Big Steps to Combat the Coronavirus
ESCHBORN, Germany, March 18, 2020 /PRNewswire/ — The German company Innoplexus AG, also known as the “Google of the healthcare industry”…
Innoplexus Opens Its Ontosight® AI Search Platform to COVID-19 Research
FRANKFURT, Germany, March 15, 2020,/PRNewswire/ — Innoplexus AG has made its proprietary Ontosight® AI search platform available to medical researchers around…
Innoplexus AG announces the appointment of Christian Bigatà Joseph as
Eschborn, 11.03.2020 – The Supervisory Board of Innoplexus AG has appointed Christian Bigatà Joseph (45) as CFO, effective as of February…
Innoplexus Consulting Services is Proud to Announce ISO/IEC 27001:2013 Certification
Pune, India, February 13, 2020 – Innoplexus Consulting Services Private Limited, a subsidiary of Innoplexus AG, is delighted to have…
Catana Capital: New collaboration with Life Science AI pioneer Innoplexus
Catana Capital partners with a leading provider of AI solutions in the Life Science sector Frankfurt am Main, December 16, 2019: As…
Innoplexus and Wiley partner to provide AI-powered solutions over comprehensive
Frankfurt, Germany, October 15, 2019 – Innoplexus AG announces a partnership with John Wiley & Sons, Inc. (NYSE: JW-A) (NYSE:…
Innoplexus and ChemAxon partner to get more out of life
Frankfurt, Germany – Budapest, Hungary, September 16, 2019 – Innoplexus announces an official partnership with ChemAxon, getting the most value…
Innoplexus Announces Appointment of Stratos Davlos as Chief Technology Officer
Hoboken, New Jersey, September 16, 2019- Innoplexus Inc., a subsidiary of Innoplexus AG, announced today the appointment of Stratos Davlos…
Traum aller Anleger
Innoplexus aus Eschborn und der Vermögensverwalter Acatis aus Frankfurt testen eine neue KI-Maschine für die Geldanlage. Der 21. März 2019 bleibt…
Innoplexus Announces Appointment of Rita Kelley as Senior Vice President
Hoboken, New Jersey, September 12, 2019 – Innoplexus Inc, a subsidiary of Innoplexus AG, Frankfurt, which has developed the most…
Innoplexus and Cures Within Reach for Cancer Tap the Power
Hoboken, NJ, August 5, 2019 – Innoplexus Holdings, Inc., a leader in artificial intelligence (AI) solutions for the life sciences…
AI CTP engine estimated failure for Biogen’s aducanumab
While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific…
Predicting Drug Flops with AI
While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific…
Google for Healthcare
Gunjan Bhardwaj chose Germany as the place to launch his advanced search and discovery solution. His company assists the healthcare…
Lessons Learned from Other Industries
While the auto industry is embracing big data and its opportunities for new services and deep insights, auto companies are…
Innoplexus Launches Worldwide Academic Access Program for its Flagship Ontosight.ai
Frankfurt, Germany, May 21, 2019 — Innoplexus announced today the launch of Ontosight Academic, a platform that provides academic researchers…
Innoplexus AG wird Mitglied im Bundesverband für Künstliche Intelligenz (KI)
Der am 16.3.2018 in München gegründete KI-Bundesverband verfolgt das Ziel, Deutschland als attraktiven Wirtschaftsstandort für die Weiterentwicklung von KI zu…
Künstliche Intelligenz auf dem Vormarsch
Veröffentlicht am 18.06.18 um 17:32 Uhr Quelle: © hessenschau Der regionale Fernsehsender Hessenschau berichtet im Rahmen der in Frankfurt am Main stattfindenden…
Big Pharma setzt auf Big Data gegen die Forschungsflaute
Die Digitalisierung wird zum Hoffnungsträger: Neue Analysen, Vernetzung sowie größere Datenmengen könnten der Arzneimittelentwicklung Schub geben. Frankfurt „Daten, überall Daten, aber…
Google für die Pharmabranche
Inder und Schwabe Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland Innoplexus aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche,…
Wir wollen Daten demokratisieren
Dr. Gunjan Bhardwaj ist Gründer und CEO der Innoplexus AG. Mit Hilfe von Künstlicher Intelligenz, Blockchain und Big-Data-Analyse-Anwendungen hat ihre…
Ein Gründer bekämpft Krebs mit künstlicher Intelligenz
Gunjan Bhardwaj hilft Pharmakonzernen, mehr über Krankheiten herauszufinden. Durch künstliche Intelligenz sollen sie schneller Medikamente entwickeln. Frankfurt. Es war ein einschneidendes…
„Deutsche Tugenden sind bei KI und Deep-Tech ein Wettbewerbsvorteil“
Christian Angermayer, Apeiron Investment Group, über die internationale KI-Szene, die Möglichkeiten, die sie eröffnet, und warum Deutschland das Potenzial hat,…
Pioniere der nächsten digitalen Revolution
Ob Medizin, Bankgeschäfte oder Mobilität: In Zukunft soll Künstliche Intelligenz aus dem Alltag nicht mehr wegzudenken sein. Hessische Unternehmer und…
INNOPLEXUS WIEDER IM GARTNER HYPE CYCLE FÜR LIFE SCIENCES
Eschborn, Januar 2019. Das weltweit angesehene US-Analystenhaus Gartner Inc. veröffentlicht jährlich seinen Hype Cycle für Life Sciences, um Unternehmensvorstände zu…
Google für die Gesundheitsbranche
Mit Freunden aus Indien hat Gunjan Bhardwaj in Deutschland Innoplexus aufgebaut – eine ausgeklügelte Suchmaschine für die Pharmabranche, die Profiwissen…
How can AI be leveraged for Clinical Trial Prediction?
Successful clinical trials occur at a ratio of 1 in 10, costing around $2-$3 billion, with drugs taking 10–12 years…
Innoplexus, a leading AI and Life Sciences company, raises double-digit
Frankfurt, Germany – Innoplexus AG, a leading global artificial intelligence (AI) company with over 80 patent applications in AI, machine…
Innoplexus’ Clinical Trial Prediction Engine predicted Aducanumab Failure
Frankfurt, Germany – On March 21st, 2019, Biogen’s stock declined sharply, showing a decrease of 29%, resulting in losses to…
An AI Firm Wants to Predicts Costly Pharma Flops
Before Biogen Inc.’s experimental Alzheimer’s disease drug failed in a trial last month, analysts surveyed by Bloomberg estimated annual sales…
Finger on the Pulse: GTC Spotlights Startups Propelling AI in
It can be hard to stay healthy in a convention center filled with thousands of people — unless, of course,…
Pharma & Healthcare Analytics Is Going To Be The Next
The Indian pharmaceutical industry has emerged as a significant contributor to the global pharmaceutical industry. As per the report by…
Innoplexus: Real-Time Data Analytics to Empower Decision Making
The evolution of artificial intelligence (AI) has taken the healthcare sector by a storm promising enhanced data analytics for effective…
8 Startups Ahead of the Pulse in Healthcare
AI enabled healthcare is swiftly becoming today’s reality, fueled by innovative startups in the field. These startups are leveraging GPUs…
Big Pharma relies on Big Data to combat the research
Digitalization is becoming a source of hope: new analyses, networking, and larger amounts of data could give a boost to…
Pharma Outlook: 12 Trends to Watch in 2019
What does 2019 have in store for Pharma? We asked industry Thought Leaders to name one disruptive trend or technology…
Mobilize data trapped in silos with Blockchain and AI
The original video was published on Talk Business 360….
Can AI help in Drug Development ?
This is the talk given by Innoplexus Co-founder & CTO, Mr. Gaurav Tripathi at DataHack 2018 – an event by…
The Story Of Disrupting AI-Driven Team
Discover the story of bringing together two worlds- AI and healthcare. Gunjan Bhardwaj, Founder and CEO of Innoplexus, guides us…
Building AI Foundation
How to build the foundations of AI your team needs?- A deep dive. Gaurav Tripathi, Co-Founder and CTO of Innoplexus,…
INNOPLEXUS INCLUDED AGAIN IN GARTNER HYPE CYCLE FOR LIFE SCIENCES
Eschborn, January 2019. The world-renowned US analyst firm Gartner Inc. annually publishes its Hype Cycle for Life Sciences to help…
How blockchain and AI can help us decipher medicine’s big
When diagnosed with a disease, it’s often overwhelming to sort through mountains of medical data to figure out what therapies…
The art of possibility: The talks of TED@Merck KGaA, Darmstadt,
The possibilities life affords us are endless. We can find them everywhere, at the micro and macro levels and across…
AI able to ‘predict impact of minor changes’ to manufacturing
Industry 4.0 has been pitched as able to transform the way pharma manufacturing operates, Lawrence Ganti……..
Blockchain in Healthcare: 6 Possible Use Cases
According to one study, the United States healthcare system ranked last among 11 industrialized nations in terms of access, equity,…
5 predictions for AI in 2019
While several companies touted the potential of AI to disrupt the drug development industry in 2018, what practical applications can…
Five AI Healthcare Startups Bringing Us Closer to Cures
Clinical Informatics tells us that: “Every year in the U.S., approximately 2 million patients participate in roughly 3000 clinical trials;…
Innoplexus Brings Blockchain to Pharma
Global AI firm Innoplexus launched an innovative blockchain platform to dramatically raise the amount of data available for drug research…
Founder fights cancer with artificial intelligence
Gunjan Bhardwaj helps pharmaceutical companies to find out more about diseases. By harnessing artificial intelligence, pharmaceutical companies are able to…
AI-based drug development to broaden gap between pharmaceuticals
Local pharmaceutical firms should brace for a new era where drugmakers take advantage of artificial intelligence (AI) to develop a…
Google for Pharma
Indian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous analytics, powered…
We want to democratize data
Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big…
How artificial intelligence impacts preventative care
With a dramatic rise in physician burnout and many physicians exiting the field prematurely, the health care industry is looking…
More transparency would bolster big pharma’s image
It’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution…
Innoplexus is working on solutions in response to GDPR and
Innoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to…
Why AI and blockchain are the solutions to developing orphan
We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on…
Who will be the disruptor that pharma is waiting for?
Companies that thrive on sustaining products over a long period are always at risk of classic disruptive innovation—losing business to…
Blockchain can take pharma collaboration and innovation to new heights
The idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds…
New Blockchain Platform from Innoplexus Will Bring Us Better, Cheaper
Redundancies in any professional field mean dollars lost. But in healthcare, inefficiency can cost lives. That’s a reality that Gunjan Bhardwaj…
How Eliminating Data Silos Will Democratize Pharma R&D
In this special guest feature, Gunjan Bhardwaj, Founder and CEO of Innoplexus, discusses how data silos in pharma prevent the…
Why blockchain is a dream come true for pharma researchers
Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries. They are…
Four steps to building an innovation culture in pharma
The quest for innovation is a major driving force in pharma. From the discovery of therapeutic biologicals in the 1920s,…
How AI and Blockchain Can Help Pharma Companies Avoid Duplicative
“If I have seen further than others, it is by standing upon the shoulders of giants.” – Isaac Newton There is…
How The Ethereum [ETH] Blockchain Is Powering The Next Generation
Ask the average person about the blockchain, and you’d be lucky if one in ten could tell you – even…
CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and
Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and…
Innoplexus launches new Blockchain platform for Pharma innovation
If your loved one was diagnosed with a potentially fatal illness, wouldn’t you want all the information possible to be…
3 Reasons why Innoplexus is bringing Blockchain to Pharma
Don’t let the hype around blockchain fool you. Blockchain is only as useful as the solutions it provides. With all the…
Innoplexus launches Blockchain platform to drive Pharma innovation
Researchers can now share unpublished data securely on the blockchain Global AI company Innoplexus launched today a groundbreaking blockchain platform to…
Beyond competition, Innoplexus believes in collaboration to nurture the ecosystem
In the last five years, data science has continued to make rapid advances, particularly in the fields of machine learning…
Gunjan Bhardwaj on “The American Dream”
Hosted by radio and TV personality Craig Sewing, ‘The American Dream’ is a national cable talk show that goes against…
When should pharma execs actually care about AI?
Artificial intelligence (AI) has recently garnered a lot of attention, and it is transforming the way pharma execs use their…
Consumer perceptions of pharma
Despite the millions of lives that are saved by pharmaceutical drugs each year, the pharmaceutical industry struggles against an enduring…
How Blockchain And AI Can Help Pharma Focus On Innovation
Pharmaceutical companies spend a tremendous amount of money each year on advertising and marketing. According to the Pew Charitable Trusts,…
How blockchain will revolutionize clinical trials
The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs. To…
Big data, AI and social media are the changing face
Pharma should lean more on the power of big data and AI to identify and target individuals who possess the…
How AI And Blockchain Can Revolutionize Pharmaceutical Trials
It’s widely known by the pharmaceutical community that nearly nine out of ten drug candidates fail to win FDA approval,…
To unlock innovation, pharma needs to be honest about failure
Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock innovation – and it’s…
How AI and blockchain can reduce corruption in Big Pharma
Gunjan Bhardwaj gives his opinion on how new technologies can help solve some of the problems in the pharma industry. The…
AI and Blockchain Platform Set to Revolutionize Drug Discovery
With the burgeoning advancement and adoption of advanced technologies such as artificial intelligence in various fields, there’s hope for a…
Blockchain and AI-based Platform iPlexus to Revolutionize Drug Discovery
Innoplexus AG announced a revolutionary update is coming soon to their iPlexus platform that will harness the power of blockchain…
German Blockchain, AI Platform to ‘Democratize’ Drug Development
Germany-based company Innoplexus AG said that iPlexus (one of its subsidiaries) will leverage blockchain technology and AI to resolve inefficiencies…
Innoplexus has been accepted to NVIDIA Inception Program
Innoplexus will now be a part of NVIDIA Inception Program. A program that is designed to nurture dedicated and exceptional…
Is Open Data the Silver Bullet for Better Drugs?
Open data sharing within the pharmaceutical industry is crucial for opening the floodgates of innovation. Successful innovation depends on having…
New Blockchain and AI-based Platform to Revolutionize Drug Discovery
Innoplexus aims to democratize drug development with launch of new iPlexus Eschborn, Germany: Innoplexus AG announced today a groundbreaking update coming…
How Blockchain leverages the Power of Failure in Drug Development
2.5 quintillion bytes of data are created every day. The challenge is to identify the relevant ones for solving a…
Innoplexus’s New North American Affiliate is Bringing AI Innovation to
It’s no secret that the American pharma industry is facing its fair share of challenges. From rising drug prices to…
Innoplexus Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies
Insights are intended to guide innovations and reforms within the industry Hoboken, New Jersey: Innoplexus, a leader in artificial intelligence and…
Innoplexus supports the European Summer School in Logic, Language and
In late 90s, internet solved the problem of data access. Then came the explosion of data with the web search…
Innoplexus Announces New North American Affiliate Helmed by Former Merck
Leader in Pharmaceutical Research AI expands North American Presence. HOBOKEN, NJ, May 10, 2018 /24-7PressRelease/ — Innoplexus, a leader in artificial intelligence and data…
Innoplexus supports the WHO “Save Lives – Clean Your Hands”
Eschborn, 5th May 2018 – Innoplexus AG supports the World Health Organization (WHO) and the Global Sepsis Alliance (GSA) by…
Why Amazon Needs AI At The Center Of Its Healthcare
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. In December 2017, Amazon, JPMorgan Chase…
Five use cases for blockchain in pharma Pharmaphorum
As blockchain expands its reach across different industries, Gunjan Bhardwaj examines some of its practical applications in the pharma industry. Blockchain…
TiE Inflect 2018 announces Innoplexus AG as a 2018 TiE50 Finalist
April 23, 2018 – Eschborn – Innoplexus AG is excited to announce that it has been selected as a “2018 TiE50…
Third Wave of Artificial intelligence promises the first AI Summit organised
Insights into the Third Wave of Artificial intelligence promises the first AI Summit organised by Innoplexus and Frankfurt School of Finance…
Drug Prices Are Too Expensive: Here’s How Technology Can Fix
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. The cost of drug development has…
Can blockchain solve pharma’s counterfeit drug problem? Pharmaphorum
Nobody doubts that fake medicines are an increasing threat to consumers and the pharma industry’s bottom line. Is blockchain the…
How Innoplexus uses smart and on-edge technology to help its
When a major global pharmaceutical company wanted to accelerate the development of a new therapy line and discover how to…
Leveraging AI and Blockchain to Transform Healthcare
Medicine is ripe for disruption. As David Lawrence, former Chairman and CEO of the Kaiser Foundation Health Plan, wrote in his…
How Blockchain Can Improve the Pharma Manufacturing Supply Chain Pharmaphorum
The entire pharmaceutical industry has been booming, from the manufacturing of clinical trial materials to support research studies to the…
Why pharma companies need to upgrade their intelligence Pharmaphorum
In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a…
How artificial intelligence powers healthcare innovation Digital Commerce 360
When medicine incorporates AI, blockchain, and big data we are going to lower costs, reduce health disparity, and speed novel…
Solving the Big Data problem in pharma innovation Pharmaphorum
The effectiveness of AI applications can be undermined by the volumes of unstructured data prevalent in the pharma industry. What…
Using AI & Machine Learning, Indo-German company Innoplexus is helping
Making more people aware about clinical trials that identify data patterns on usage of a particular drug to discover if it can…
How AI, blockchain, and big data can reduce drug development
Cutting-edge technologies are increasingly improving pharma’s R&D processes, which will reduce costs and, in turn, benefit patients, says Gunjan Bhardwaj. It’s…
How AI Is Transforming The Future Of Healthcare
Post Written ByGunjan Bhardwaj Dr. Gunjan Bhardwaj is Co-Founder and Chief Executive of Innoplexus AG. I recently wrote about five technologies…
Innoplexus strengthens its global leadership team with accomplished leaders- appoints
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today…
Gaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence
Innoplexus AG, a leading AI based analytics as a service provider in life sciences and financial services domain, announced today…
Innoplexus @ Machine Intelligence Summit, Berlin 2017
Innoplexus AG proudly announces that our founder and CEO, Dr Gunjan Bhardwaj will be on the panel discussion at Machine…
Accelerating innovation in Pharma with Artificial Intelligence & Big Data
As Kevin Rands, (a contributor at CIO.com) has stated in his blog “Data is the lifeline of any business”, and…
Partex and Singapore’s Experimental Drug Development Centre collaborate to bring
Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to…
Partex NV announces collaboration with Althea DRF Lifesciences to provide
Frankfurt, Germany; 28 March 2024 – Partex Group, a pioneer in AI-driven drug discovery, announces a collaboration with Althea DRF…
Innovative AI technology in oncology: Partex Group presents results from
During the German Cancer Congress 2024 in Berlin, the companies Innoplexus AG /Amrit AG, companies of Partex N.V., presented the…
Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment
Frankfurt, Germany; 14 March 2024 Partex Group, a pioneer in AI-driven drug discovery, today announces a collaboration with global pharmaceutical…
Innoplexus and AIO Studien gGmbH are jointly announcing the start
January 02, 2024 – Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health…
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased
Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…
AI supports targeted therapy recommendations fortumor diseases – BMBF funds
The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary…
Innoplexus and Innovatrix capital partner to bring about new risk-transfer
Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning…
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30,…